Pneumonitis is a noninfectious inflammatory process of the lung parenchyma — primarily involving the alveoli, alveolar walls, and pulmonary interstitium — triggered by a variety of non-microbial insults including inhaled organic antigens, chemical fumes, aspirated substances, ionizing radiation, drugs/medications, and autoimmune or connective tissue disease. Unlike pneumonia, where pathogen replication is the central driver, pneumonitis is fundamentally an injurious or hypersensitivity-mediated inflammatory response that damages lung tissue without a living infectious organism actively proliferating in the alveolar space. The inflammatory cascade results in alveolar wall thickening, interstitial edema, and impaired gas exchange, which clinically presents as dyspnea, dry cough, hypoxia, and fatigue — often insidious and subacute rather than the acute febrile presentation typical of bacterial pneumonia. Radiographically, pneumonitis typically produces ground-glass opacities, reticular infiltrates, and honeycombing on HRCT rather than the lobar consolidation seen in bacterial pneumonia. As an inpatient profee coder, pneumonitis is a diagnosis you must interrogate carefully — the etiology dramatically changes your code, and the etiology is almost always buried in the pulm or ID consult, the medication list, or the occupational/exposure history. J68.0 (chemical/fumes/vapors), J67.9 (hypersensitivity pneumonitis, unspecified organic dust), J70.2 (acute drug-induced), and J84.114 (acute interstitial pneumonitis/Hamman-Rich syndrome) are worlds apart clinically and from a DRG-impact standpoint — never let a vague “pneumonitis” go unclarified.
“Inflammation of” — the standard Greek/Latin suffix appended to anatomical terms to denote an inflammatory condition of the named structure
The word pneumonitis is a compound formed in Modern Medical Latin from the Ancient Greek πνεύμων (pneumōn, “lung”) + -itis (inflammation), paralleling the construction of terms like hepatitis, nephritis, and meningitis. The combining root pneumon- traces back to πνεῖν (pneîn, “to breathe”) and is closely related to pneumo-, the other dominant combining form for lung-related terminology. The term was constructed in the 19th century as physicians and pathologists needed a word to distinguish sterile inflammatory lung disease from the infectious pneumonia — recognizing that the lung could become severely inflamed without active infection. The suffix -itis carries an implied meaning of inflammatory pathology and is one of the most productive suffixes in all of medical terminology, used across virtually every organ system.
Ventilation assist and management, each subsequent inpatient day
⚠️ Coding Note:Etiology is everything in pneumonitis coding — the difference between J67.9 (HP), J68.0 (chemical), J69.0 (aspiration), J70.2 (drug-induced), and J84.114 (acute interstitial/Hamman-Rich) is the entire medical record. Never assign a pneumonitis code without first identifying the trigger documented by the physician. J69.0 (aspiration pneumonitis) requires explicit documentation of aspiration — you cannot code it from tube-feeding status or dysphagia alone; query the pulmonologist or hospitalist if the mechanism is unclear. J70.2 and J70.3 (drug-induced) require an additional adverse effect code from the T36-T50 range with the appropriate 6th character “5” (adverse effect) — always sequence the lung disorder first, then the adverse effect T-code. J84.114 (Hamman-Rich / AIP) is an MCC and is frequently missed when teams document vague “acute ILD” or “interstitial pneumonitis” — push for specificity via query. For HP codes under J67.x, organism or antigen source specificity (farmer’s lung vs. bird fancier’s lung vs. air conditioner lung) drives the specific code and demonstrates clinical precision. For inpatient profee, 94729 (DLCO/diffusing capacity) and 94726 (body plethysmography) are high-value PFT codes routinely missed when the pulmonologist only documents “PFTs performed” — verify the specific components ordered and interpreted by the billing provider.